Literature DB >> 3082755

Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.

T Yokokura, K Nomoto, T Shimizu, K Nomoto.   

Abstract

Mice that had received heat-killed Lactobacillus casei (LC 9018) subcutaneously (s.c.) showed enhanced resistance to systemic (i.e., intravenous) infection with Listeria monocytogenes, but the antilisterial resistance of mice was less augmented by s.c. administration of Propionibacterium acnes ("Corynebacterium parvum"). Though there was little change in the total number of splenic leukocytes after s.c. administration of LC 9018, the monocyte-macrophage ratio increased after treatment, reaching its peak on day 5 to 7 after injection. The number of progenitor cells that form macrophage colonies under the stimulus of L-cell-conditioned medium in a semisolid agar culture system increased in the spleens of mice pretreated s.c. with LC 9018, showing a peak response on day 5 after injection. The increase corresponded to the increase in the dose administered, and increased numbers were detected even 10 days after treatment. The number of macrophage colonies in the femurs of mice pretreated s.c. with LC 9018 showed a temporary increase on day 3 after injection but then a decrease until day 10. Colony-stimulating activity was detected in the sera of mice administered LC 9018 s.c. 18 h previously, and the colonies produced were of three types: granulocyte (8%), macrophage (56%), and granulocyte-macrophage (36%). Administration of C. parvum s.c. had little effect on these hematopoietic responses of mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082755      PMCID: PMC262212          DOI: 10.1128/iai.52.1.156-160.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Effect of Corynebacterium parvum on colony-stimulating factor and granulocyte-macrophage colony formation.

Authors:  R S Foster; B R MacPherson; D A Browdie
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

2.  The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.

Authors:  N Wolmark; M Levine; B Fisher
Journal:  J Reticuloendothel Soc       Date:  1974-10

3.  Three phases of phagocyte contribution to resistance against Listeria monocytogenes.

Authors:  M Mitsuyama; K Takeya; K Nomoto; S Shimotori
Journal:  J Gen Microbiol       Date:  1978-05

4.  On the mechanism of T cell-independent anti-Listeria resistance in nude mice.

Authors:  M F Newborg; R J North
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

5.  Inhibition of tumour growth by administration of killed corynebacterium parvum.

Authors:  B N Halpern; G Biozzi; C Stiffel; D Mouton
Journal:  Nature       Date:  1966-11-19       Impact factor: 49.962

6.  Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages.

Authors:  E Handman; A W Burgess
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

7.  Granulocyte-macrophage precursor cell and colony-stimulating factor responses of mice infected with Salmonella typhimurium.

Authors:  A Trudgett; T A McNeill; M Killen
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

8.  The molecular weight of colony-stimulating factor (CSF).

Authors:  E R Stanley; D Metcalf
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

9.  Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei.

Authors:  K Nomoto; S Miake; S Hashimoto; T Yokokura; M Mutai; Y Yoshikai; K Nomoto
Journal:  J Clin Lab Immunol       Date:  1985-06

10.  Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.

Authors:  V H Freedman; T A Calvelli; S Silagi; S C Silverstein
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more
  8 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Prevention of B220+ T cell expansion and prolongation of lifespan induced by Lactobacillus casei in MRL/lpr mice.

Authors:  A Mike; N Nagaoka; Y Tagami; M Miyashita; S Shimada; K Uchida; M Nanno; M Ohwaki
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

3.  Prevention of indigenous infection of mice with Escherichia coli by nonspecific immunostimulation.

Authors:  K Nomoto; T Yokokura; M Mitsuyama; Y Yoshikai; K Nomoto
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  The role of lymph node cells in the inhibition of metastasis by subcutaneous injection of Lactobacillus casei in mice.

Authors:  T Matsuzaki; T Yokokura; M Mutai
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

5.  Production of colony-stimulating factors during pneumonia caused by Chlamydia trachomatis.

Authors:  D M Magee; D M Williams; E J Wing; C A Bleicker; J Schachter
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

6.  Role of macrophages in serum colony-stimulating factor induction by Lactobacillus casei in mice.

Authors:  M Nanno; T Shimizu; A Mike; M Ohwaki; M Mutai
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

7.  Transposon mutagenesis of probiotic Lactobacillus casei identifies asnH, an asparagine synthetase gene involved in its immune-activating capacity.

Authors:  Masahiro Ito; Yun-Gi Kim; Hirokazu Tsuji; Takuya Takahashi; Mayumi Kiwaki; Koji Nomoto; Hirofumi Danbara; Nobuhiko Okada
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  Effect of human macrophage colony-stimulating factor on granulopoiesis and survival in bone-marrow-transplanted mice.

Authors:  N Yanai; M Yamada; K Motoyoshi; H Yokota; K Yoshida; M Saito; T Kawashima; M Nishida; Y Miura; M Saito
Journal:  Jpn J Cancer Res       Date:  1990-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.